MIST vs ORLY · rev $797.0K vs P/E 34, rev $9.45B
Milestone Pharmaceuticals Inc (MIST) versus O’Reilly Automotive Inc (ORLY) — a side-by-side from cached financials, not a winner call.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
Latest reported ORLY revenue for 2026-06-30 was $9.45B. Net income was $1.32B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
MIST currently screens at market cap $160.6M. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Not investment advice. Open the MIST and ORLY stock pages for the full models.
Not investment advice.